News
The new expansion is linked to a partnership the digital health company has with Novartis.
A frequent partner of biopharmas and the FDA, it has raised $94 million from investors since its commercial launch in 2015.
The raise reportedly brings the company's valuation into unicorn territory.
Dubbed Coefficient Insurance Company, it will combine Verily and Swiss Re Corporate Solutions' technology.
The deal joins each company's voice sample datasets to improve R&D, and helps Sonde collect more data across platforms.
Google's cloud division poured in $100 million in funding to the telehealth company, along with the deal.
PatientPop says it will use these funds to continue to provide practices with the tools they need to give patients both in-person and online.
Under the banner of the Consumer Technology Association, the companies hope that clear standards will improve digital therapeutics adoption and implementation.
The company released three new products today that are available today for preorder on Fitbit’s website and will be sold worldwide in late September.
The consumer genomics company's existing offering, called AncestryHealth, sold clinician-ordered tests that were not cleared or approved by the FDA.